Comparing new participants of a mobile versus a pharmacy-based needle exchange program.

Important note: Information in this article was accurate in 2000. The state of the art may have changed since the publication date.

Comparing new participants of a mobile versus a pharmacy-based needle exchange program.

J Acquir Immune Defic Syndr. 2000 May 1;24(1):57-61. Unique Identifier : AIDSLINE MED/20334007
Riley ED; Safaeian M; Strathdee SA; Marx MA; Huettner S; Beilenson P; Vlahov D; Department of Epidemiology, The Johns Hopkins School of Hygiene; and Public Health, Baltimore, Maryland, USA.

Abstract: OBJECTIVE: To compare characteristics of first-time needle exchange participants who enrolled at a mobile van-based exchange site versus a fixed pharmacy-based exchange site, in an area where both types of needle exchange programs were available. METHODS: Demographic and drug use data were collected on needle exchange program participants on enrollment. Participants were included if they were first-time participants at the Baltimore needle exchange program between December 1997 and March 1999, and if their first visit was at either one van-based site or at one of two pharmacy-based sites. Descriptive statistics and inferences were based on the type of needle exchange into which participants enrolled. RESULTS: Among 286 first-time participants, 92% were African American, 28% were women, 11% were currently employed, 55% completed high school, and the median age was 40 years. In multivariate analyses, van-based enrollment was more common among frequent injectors (odds ratio [OR] = 2.0), but less common among African American participants (OR = 0.21). CONCLUSIONS: Our data suggest that different venues for needle exchange program settings attract different types of drug injecting participants. This suggests that offering different venue types to reach participants with differing drug use patterns will be important to optimize risk reduction strategies.

Keywords: JOURNAL ARTICLE Adult Comparative Study Female Human Male Needle-Exchange Programs/METHODS/STATISTICS & NUMER DATA/ *UTILIZATION *Substance Abuse, Intravenous Support, U.S. Gov't, P.H.S.
001030
A00A1051

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Elton John AIDS Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2000. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .